Authors' Reply: Endopeptidase Therapy for Anti-Glomerular Basement Membrane Disease: Beware of Anti-Hinge Antibodies!
- PMID: 35948436
- PMCID: PMC9528339
- DOI: 10.1681/ASN.2022070747
Authors' Reply: Endopeptidase Therapy for Anti-Glomerular Basement Membrane Disease: Beware of Anti-Hinge Antibodies!
Keywords: anti-GBM disease; glomerulonephritis.
Comment on
-
Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study.J Am Soc Nephrol. 2022 Apr;33(4):829-838. doi: 10.1681/ASN.2021111460. Epub 2022 Mar 8. J Am Soc Nephrol. 2022. PMID: 35260419 Free PMC article. Clinical Trial.
-
Endopeptidase Therapy for Anti-Glomerular Basement Membrane Disease: Beware of Anti-Hinge Antibodies!J Am Soc Nephrol. 2022 Oct;33(10):1953-1954. doi: 10.1681/ASN.2022050609. Epub 2022 Aug 10. J Am Soc Nephrol. 2022. PMID: 35948435 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources